The Oropouche Virus: Emerging Arboviral Threats in the Americas

Oropouche virus (OROV) is an emerging arbovirus primarily transmitted by the Culicoides mosquito species. It was first identified in 1955 in the Amazon region of Brazil and has since been recognized as a cause of viral fever outbreaks, particularly in Latin America. The virus typically causes an illness characterized by fever, headache, muscle and joint pain, rash, retro- orbital pain, conjunctivitis, and gastrointestinal symptoms like nausea and vomiting. Neurological manifestations, including confusion and, in rare cases, encephalitis, can also occur. Outbreaks of OROV have been reported, especially in areas with poor vector control and high mosquito populations. Diagnosis is confirmed through laboratory tests, including reverse transcription polymerase chain reaction (RT-PCR) and serological assays to detect antibodies or viral RNA. This review provides a fresh view and insight into the OROV research arena by drawing attention to several major issues important for advancing research and public health response. One major topic that the review brings out is the sudden increase in reports of outbreaks and cases in Brazil, Peru, and Bolivia. This seems to contribute to the growing recognition of OROV as a big public health threat. Emphasizing the potential new transmission routes by OROV, there are calls for further studies, and monitoring should be strengthened to avert further spread. The molecular and structural approaches have been discussed in this review, thereby providing knowledge about the OROV at the biological level. The information about the segmented RNA genome and the proteins encoded by the three segments helps the understanding of molecular attributes contributing to viral replication and infectivity in host cells. A detailed analysis of the virus's structure will form a fundamental basis for further research directed toward therapeutics and vaccine development. Finally, the review highlights the need for urgent vaccine development and enhanced prevention strategies. Until now, no approved vaccines or antiviral treatment options have been available; therefore, the review promotes further research into uptake-based vaccine approaches and enhanced vector control. Emphasis on practicable prevention measures encompassing the use of insect repellents, mosquito nets, and curtailing breeding grounds allows public health personnel and communities to take concrete measures to intercept the virus's further spread. Middle of these recommendations, bolstered by increasing evidence about the virus's epidemiology, makes the review a timely call for action to address this emerging threat.